Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$163
-$1,313 QoQ
Shares Held
3
-92.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#747
of 751 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROSS\JOHNSON & Associates LLC holds $6,199 across 12 Biotechnology names. EXEL ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
63 | $4,450 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1 | $496 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1 | $301 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1 | $240 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
3 | $163 | |
| 6 | MRNA |
Moderna, Inc.
|
2 | $140 | |
| 7 | ABVX |
Abivax S.A.
|
1 | $133 | |
| 8 | INCY |
Incyte Corp
|
1 | $113 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163 | 3 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,476 | 40 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||